• Deferasirox Pharmacokinetics and Clinical Impact in Iron Ove

  2026-07-01

  The referenced review by Galanello et al. provides a thorough analysis of Deferasirox (Exjade) as an oral iron chelator, focusing on its pharmacokinetics, efficacy, and safety for iron overload in transfusion-dependent anemias. Their synthesis of clinical trial data highlights the compound's advantages in patient compliance and disease management, while also emphasizing the ongoing need for individualized dosing and monitoring.

• Pronase E Protease Mixture: Unraveling Proteostasis in Cance

  2026-07-01

  Explore the unique role of Pronase E, a high-activity protease mixture, in proteostasis analysis and protein sample preparation for advanced molecular biology. This article reveals new assay strategies, mechanistic insights, and translational perspectives beyond standard protocols.

• Applied Advances with mCherry mRNA: Protocols, Performance,

  2026-06-30

  EZ Cap™ mCherry mRNA (5mCTP, ψUTP) sets the benchmark for robust, immune-evasive red fluorescent protein mRNA expression in cell biology. With optimized capping and nucleotide modifications, it enables reproducible, high-fidelity assays where suppression of innate immunity and translational efficiency are critical.

• Phosbind Acrylamide: Transforming Protein Phosphorylation An

  2026-06-30

  Phos binding reagent (Phosbind) acrylamide streamlines SDS-PAGE-based phosphorylation analysis, enabling high-resolution mobility shift detection without phospho-specific antibodies. Its application accelerates workflows in signal transduction and kinase activity assays, empowering researchers to dissect complex phosphorylation dynamics with precision.

• Gasdermin C Regulates Stemness and Immune Evasion in PDAC

  2026-06-29

  This study uncovers a novel, pyroptosis-independent mechanism by which Gasdermin C (GSDMC) enhances stemness and immune evasion in pancreatic ductal adenocarcinoma (PDAC). By elucidating GSDMC’s nuclear actions and its impact on the tumor microenvironment, the research identifies new therapeutic targets to improve immunotherapy responses in this aggressive cancer.

• Cy5-UTP: Precision RNA Labeling for FISH & Expression Arrays

  2026-06-29

  Cy5-UTP (Cyanine 5-uridine triphosphate) empowers researchers to generate highly sensitive, fluorescently labeled RNA probes for advanced applications like FISH and dual-color expression arrays. This guide offers robust workflows, troubleshooting insights, and practical tips to harness Cy5-UTP’s full potential in visualizing RNA and dissecting RNA–protein assemblies.

• Tetracycline: Broad-Spectrum Polyketide Antibiotic in Modern

  2026-06-28

  Tetracycline, supplied by APExBIO, is more than a classic antibiotic—it's a precision tool for ribosomal function studies, membrane integrity assays, and robust antibiotic selection in molecular biology. This article provides actionable protocols, advanced workflows, and troubleshooting strategies, uniquely bridging foundational microbiology with cutting-edge translational research.

• Translatome Remodeling, Ketogenesis, and Tumorigenesis via t

  2026-06-27

  Yang et al. (2024) reveal that fasting induces specific remodeling of the hepatic translatome, mediated by increased phosphorylation of eIF4E via the AMPK-MNK pathway. This process is essential for ketogenesis and offers a metabolic vulnerability in pancreatic tumorigenesis, linking dietary intervention with translational control and cancer therapy.

• CLK2 Inhibition to Overcome Platinum Resistance in Ovarian C

  2026-06-26

  This article examines recent evidence that Cdc2-like kinase 2 (CLK2) drives platinum resistance in ovarian cancer by enhancing DNA repair. The study's mechanistic insights and translational implications highlight the importance of CLK2 as a target for overcoming chemoresistance, providing a rationale for using selective Clk inhibitors in preclinical research.

• Cisplatin (SKU A8321): Reliable Solutions for Cancer Researc

  2026-06-26

  This scenario-driven article addresses real laboratory challenges in cancer research, highlighting how Cisplatin (SKU A8321) provides reproducible, evidence-backed solutions for assays involving cell viability, apoptosis, and chemotherapy resistance. Bench researchers and lab technicians will find actionable best practices and protocol optimizations, grounded in recent scientific literature and APExBIO’s validated product data.

• Regorafenib (BAY 73-4506): Mechanistic Insights and Research

  2026-06-25

  Regorafenib (BAY 73-4506) is a potent, oral multikinase inhibitor central to angiogenesis and cancer biology research. Recent studies confirm its ability to suppress tumor growth, invasion, and metastasis by targeting key signaling pathways, including RRM2 and ERK/E2F3. These properties position Regorafenib as a valuable tool for dissecting oncogenic mechanisms and evaluating translational interventions.

• ATRX Deficiency Sensitizes High-Grade Glioma to PDGFR Inhibi

  2026-06-25

  Pladevall-Morera et al. reveal that high-grade glioma cells lacking ATRX are especially sensitive to receptor tyrosine kinase (RTK) and PDGFR inhibitors. These findings highlight ATRX status as a potential biomarker for targeted therapy selection and suggest new avenues for improving treatment responses in aggressive gliomas.

• VX-765: Potent Caspase-1 Inhibition for Pyroptosis Research

  2026-06-24

  VX-765, a highly selective oral caspase-1 inhibitor, empowers researchers to dissect inflammation and pyroptosis pathways with precision. Its robust performance in cell-based and in vivo models sets a new standard for targeted cytokine modulation and translational disease research.

• Biotin-tyramide: Protocols and Troubleshooting for TSA Workf

  2026-06-23

  Biotin-tyramide is a high-purity biotinylation reagent tailored for tyramide signal amplification (TSA) applications in immunohistochemistry (IHC) and in situ hybridization (ISH). It addresses the need for spatially precise, high-sensitivity detection in fixed tissue and cell imaging. This reagent is not recommended for diagnostic or direct medical use, and its application is limited to research workflows that utilize HRP-mediated signal amplification.

• N3-kethoxal: Advancing RNA Secondary Structure Probing

  2026-06-23

  N3-kethoxal, a membrane-permeable azide-functionalized probe, enables high-resolution mapping of RNA and DNA structure in living cells or in vitro. Its robust click chemistry compatibility and selective guanine labeling streamline workflows for RNA-protein interaction discovery and genomic accessibility mapping.

14947 records 1/997 page Next 12345 下5页 Last page